KD Logo

QuidelOrtho Corporation [QDEL] stock was sold by Carlyle Group Inc. at the price of US$1.58 million

QuidelOrtho Corporation’s filing revealed that its 10% Owner Carlyle Group Inc. unloaded Company’s shares for reported $1.58 million on Jul 05 ’24. In the deal valued at $31.15 per share,50,739 shares were sold. As a result of this transaction, Carlyle Group Inc. now holds 11,249,724 shares worth roughly $341.54 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Carlyle Group Inc. sold 52,724 shares, generating $1,627,441 in total proceeds. Upon selling the shares at $30.87, the 10% Owner now owns 11,300,463 shares.

Before that, Carlyle Group Inc. sold 86,454 shares. QuidelOrtho Corporation shares valued at $2,711,095 were divested by the 10% Owner at a price of $31.36 per share. As a result of the transaction, Carlyle Group Inc. now holds 11,353,187 shares, worth roughly $344.68 million.

UBS downgraded its QuidelOrtho Corporation [QDEL] rating to a Sell from a a Neutral in a research note published on March 04, 2024; the price target was decreased to $42 from $70. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid February from “a Neutral” to “an Underweight”. Citigroup also remained covering QDEL and has decreased its forecast on December 11, 2023 with a “Neutral” recommendation from previously “Buy” rating. Citigroup revised its rating on December 12, 2022. It rated QDEL as “a Buy” which previously was an “a Neutral”.

Price Performance Review of QDEL

On Monday, QuidelOrtho Corporation [NASDAQ:QDEL] saw its stock fall -2.88% to $30.36. Over the last five days, the stock has lost -8.61%. QuidelOrtho Corporation shares have fallen nearly -58.81% since the year began. Nevertheless, the stocks have fallen -63.21% over the past one year. While a 52-week high of $89.11 was reached on 01/02/24, a 52-week low of $30.61 was recorded on 07/08/24. SMA at 50 days reached $39.61, while 200 days put it at $55.62. A total of 0.93 million shares were traded, compared to the trading of 1.11 million shares in the previous session.

Levels Of Support And Resistance For QDEL Stock

The 24-hour chart illustrates a support level at 29.70, which if violated will result in even more drops to 29.05. On the upside, there is a resistance level at 31.38. A further resistance level may holdings at 32.40. The Relative Strength Index (RSI) on the 14-day chart is 21.31, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.80%. Stochastics%K at 6.09% indicates the stock is a buying.

The most recent change occurred on December 07, 2022 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $125 price target.

Most Popular